Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Todd C. Brady currently holds 14,625 shares of Oncobiologics, Inc. (ONS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Todd C. Brady has been a net buyer of ONS stock. They have purchased $874.9K and sold $580.4K worth of shares.
Todd C. Brady's most recent insider trade was on Dec 16, 2025, when they sold 27 shares at $0.00 per share.
Todd C. Brady serves as Executive at Oncobiologics, Inc. (ONS). They have executed 46 insider transactions totaling $1.5M over their tenure at the company.
Todd C. Brady holds the position of Executive at Oncobiologics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 12 years and currently hold a stake valued at $0.
Todd C. Brady has shown a buying trading pattern, with $874.9K in total purchases and $580.4K in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Todd C. Brady was on Sep 7, 2023, when they sold $532.9K worth of ALDX shares. This transaction involved 73,807 shares at $7.22 per share.
Todd C. Brady currently owns 14,625 shares of Oncobiologics, Inc. (ONS), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Todd C. Brady's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Todd C. Brady has 46 Form 4 filings on record as an insider at Oncobiologics, Inc..
Set alerts for Todd C. Brady and 40,000+ other insiders.